Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Porcine FGF19 ELISA Kit (AC2975)
Cat.#: ASET-1564
Specifications
Description Porcine FGF19 ELISA Kit allows for the in vitro quantitative determination of porcine FGF19 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Porcine Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1899 Human Vimentin ELISA Kit (AC3310) Quantitative inquiry ASET-1185 Human NMDAR2A ELISA Kit (AC2596) Quantitative inquiry ASET-1297 Rat Myelin Basic Protein ELISA Kit (AC2708) Quantitative inquiry ASET-2015 Human Visfatin ELISA Kit (AC3426) Quantitative inquiry ASET-1607 Human Glutamine Synthetase ELISA Kit (AC3018) Quantitative inquiry ASET-2340 Mouse alpha MSH ELISA Kit (AC3751) Quantitative inquiry ASET-2121 Human CaSR ELISA Kit (AC3532) Quantitative inquiry ASET-1771 Rat Neuroglobin ELISA Kit (AC3182) Quantitative inquiry ASET-1764 Human NRG1 ELISA Kit (AC3175) Quantitative inquiry ASET-2395 Mouse Nrg2 ELISA Kit (AC3806) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket